Proliferating cell nuclear antigen
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 20: 5.11 – 5.13 Mb | Chr 2: 132.09 – 132.1 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
![](http://upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Cryo-EM_structure_of_the_DNA-bound_PolD%E2%80%93PCNA_processive_complex.pdf/page1-220px-Cryo-EM_structure_of_the_DNA-bound_PolD%E2%80%93PCNA_processive_complex.pdf.jpg)
Proliferating cell nuclear antigen (PCNA) is a
Many proteins interact with PCNA via the two known PCNA-interacting motifs PCNA-interacting peptide (PIP) box[6] and AlkB homologue 2 PCNA interacting motif (APIM).[7] Proteins binding to PCNA via the PIP-box are mainly involved in DNA replication whereas proteins binding to PCNA via APIM are mainly important in the context of genotoxic stress.[8]
Function
The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome.[9]
PCNA is also found in archaea, as a processivity factor of polD, the single multi-functional DNA polymerase in this domain of life.[10]
Expression in the nucleus during DNA synthesis
PCNA was originally identified as an
Role in DNA repair
Since DNA polymerase epsilon is involved in resynthesis of excised damaged DNA strands during DNA repair, PCNA is important for both DNA synthesis and DNA repair.[17][18]
PCNA is also involved in the DNA damage tolerance pathway known as post-replication repair (PRR).[19] In PRR, there are two sub-pathways: (1) a
PCNA-binding proteins
PCNA interacts with many proteins.[22]
- Apoptotic factors
- ATPases
- Base excision repair enzymes
- Cell-cycle regulators
- Chromatin remodeling factor
- Clamp loader
- Cohesin
- DNA ligase
- DNA methyltransferase
- DNA polymerases
- E2 SUMO-conjugating enzyme
- E3 ubiquitin ligases
- Flap endonuclease
- Helicases
- Histone acetyltransferase
- Histone chaperone
- Histone deacetylase
- Mismatch repairenzymes
- Licensing factor
- NKp44receptor
- Nucleotide excision repair enzyme
- Poly ADP ribose polymerase
- Procaspases[23]
- Protein kinases
- TCP protein domain
- Topoisomerase
Interactions
PCNA has been shown to
- Annexin A2[24]
- CDC25C[28]
- CHTF18[24]
- Cyclin D1[29][30]
- Cyclin O[24][31]
- Cyclin-dependent kinase 4[30][32]
- Cyclin-dependent kinase inhibitor 1C[33]
- DNMT1[34][35][36]
- EP300[37]
- Establishment of Sister Chromatid Cohesion 2[38]
- Flap structure-specific endonuclease 1[39][40][41][42][43][44][45]
- GADD45A[46][47][48][49][50]
- GADD45G[51][52]
- HDAC1[53]
- HUS1[54]
- ING1[55]
- KCTD13[56]
- KIAA0101[45]
- Ku70[24][57]
- Ku80[24][57][58]
- MCL1[59]
- MSH3[24][60][61]
- MSH6[24][60][61]
- MUTYH[62]
- P21[33][41][45][63][64][65][66][67]
- POLD2[68]
- POLD3[24][69]
- POLDIP2[70]
- POLH[71]
- RFC1[24][63][75][76][77]
- RFC2[24][78][79]
- RFC3[24][80]
- RFC4[24][78]
- RFC5[24][76][78]
- Ubiquitin C[81][82][83]
- XRCC1[86]
- Y box binding protein 1[87]
Proteins interacting with PCNA via APIM include human AlkB homologue 2, TFIIS-L, TFII-I, Rad51B,[7] XPA,[88] ZRANB3,[89] and FBH1.[90]
Uses
On the other hand, the study of the dynamics of replication and repair in living cells can be done by introducing translational fusions of PCNA. To eliminate the need for transfection and bypass the problem of difficult to transfect and/or short lived cells, cell permeable replication and/or repair markers can be used. These peptides offer the distinct advantage that they can be used in situ in living tissue and even distinguish cells undergoing replication from cells undergoing repair.[92]
caPCNA, a post-translationally modified isoform of PCNA common in cancer cells, is a potential therapeutic target in cancer therapy.[93][94] In 2023 City of Hope National Medical Center published preclinical research on a targeted chemotherapy using AOH1996 that appears to suppress tumor growth without causing discernable side effects.[95]
See also
- Ki-67 – cellular marker for proliferation
- Transcription
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000132646 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027342 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- S2CID 3547069.
- PMID 9631646.
- ^ PMID 19736315.
- S2CID 25952152.
- ^ "Entrez Gene: PCNA proliferating cell nuclear antigen".
- PMID 32221299.
- PMID 1350788.
- PMID 2884104.
- S2CID 4346799.
- PMID 10051561.
- PMID 12468739.
- PMID 26833126.
- S2CID 12260457.
- PMID 16227586.
- PMID 16956796.
- ^ S2CID 205209495.
- S2CID 4316517.
- S2CID 3547069.
- PMID 20975039.
- ^ PMID 12171929.
- PMID 26908650.
- PMID 10648606.
- PMID 19822659.
- PMID 11896603.
- PMID 7908906.
- ^ PMID 8101826.
- PMID 10393198.
- S2CID 4368128.
- ^ PMID 9465025.
- S2CID 26149386.
- S2CID 25310911.
- PMID 9302295.
- S2CID 2129847.
- PMID 31879348.
- PMID 12853968.
- PMID 11430825.
- ^ PMID 9545252.
- PMID 9305916.
- PMID 8876181.
- PMID 11601988.
- ^ PMID 11313979.
- PMID 7973727.
- PMID 7478510.
- PMID 10828065.
- PMID 7784094.
- PMID 10973963.
- PMID 11022036.
- PMID 10455148.
- PMID 11929879.
- PMID 11077446.
- PMID 11682605.
- PMID 11593007.
- ^ PMID 11239001.
- PMID 12393188.
- PMID 10978339.
- ^ PMID 11274057.
- ^ PMID 11005803.
- PMID 11092888.
- ^ PMID 8861969.
- S2CID 4427026.
- PMID 12930846.
- S2CID 17461501.
- PMID 11350925.
- PMID 11986310.
- PMID 11595739.
- PMID 12522211.
- PMID 11585903.
- PMID 11784855.
- PMID 12368291.
- S2CID 29714829.
- PMID 12192049.
- ^ PMID 8999859.
- S2CID 22183443.
- ^ PMID 9228079.
- PMID 8093561.
- PMID 12766176.
- PMID 18719106.
- PMID 18316726.
- PMID 18284681.
- S2CID 37287691.
- PMID 10871373.
- PMID 15107487.
- PMID 9927044.
- PMID 23152873.
- PMID 22704558.
- PMID 23677613.
- PMID 26022740.
- PMID 25484186.
- PMID 24655521.
- PMID 29967249.
- PMID 37531956.
Further reading
- Almendral JM, Huebsch D, Blundell PA, Macdonald-Bravo H, Bravo R (March 1987). "Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins". Proceedings of the National Academy of Sciences of the United States of America. 84 (6): 1575–1579. PMID 2882507.
- Chen IT, Smith ML, O'Connor PM, Fornace AJ (November 1995). "Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA". Oncogene. 11 (10): 1931–1937. PMID 7478510.
- Chen M, Pan ZQ, Hurwitz J (April 1992). "Sequence and expression in Escherichia coli of the 40-kDa subunit of activator 1 (replication factor C) of HeLa cells". Proceedings of the National Academy of Sciences of the United States of America. 89 (7): 2516–2520. PMID 1313560.
- Fukuda K, Morioka H, Imajou S, Ikeda S, Ohtsuka E, Tsurimoto T (September 1995). "Structure-function relationship of the eukaryotic DNA replication factor, proliferating cell nuclear antigen". The Journal of Biological Chemistry. 270 (38): 22527–22534. PMID 7673244.
- Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS (June 1995). "Characterisation of the interaction between PCNA and Gadd45". Oncogene. 10 (12): 2427–2433. PMID 7784094.
- Kato S, Sekine S, Oh SW, Kim NS, Umezawa Y, Abe N, et al. (December 1994). "Construction of a human full-length cDNA bank". Gene. 150 (2): 243–250. PMID 7821789.
- Kemeny MM, Alava G, Oliver JM (November 1992). "Improving responses in hepatomas with circadian-patterned hepatic artery infusions of recombinant interleukin-2". Journal of Immunotherapy. 12 (4): 219–223. PMID 1477073.
- Krotz D (28 July 2004). "Structure of a clamp–loader complex". ALSNews. Vol. 243. Lawrence Berkeley National Laboratory. Archived from the original on 11 October 2004. Retrieved 3 August 2023.
- Ku DH, Travali S, Calabretta B, Huebner K, Baserga R (July 1989). "Human gene for proliferating cell nuclear antigen has pseudogenes and localizes to chromosome 20". Somatic Cell and Molecular Genetics. 15 (4): 297–307. S2CID 27217843.
- Li X, Li J, Harrington J, Lieber MR, Burgers PM (September 1995). "Lagging strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen". The Journal of Biological Chemistry. 270 (38): 22109–22112. PMID 7673186.
- Matsuoka S, Yamaguchi M, Matsukage A (April 1994). "D-type cyclin-binding regions of proliferating cell nuclear antigen". The Journal of Biological Chemistry. 269 (15): 11030–11036. PMID 7908906.
- Miura M (March 1999). "Detection of chromatin-bound PCNA in mammalian cells and its use to study DNA excision repair". Journal of Radiation Research. 40 (1): 1–12. PMID 10408173.
- Miyata T, Suzuki H, Oyama T, Mayanagi K, Ishino Y, Morikawa K (September 2005). "Open clamp structure in the clamp-loading complex visualized by electron microscopic image analysis". Proceedings of the National Academy of Sciences of the United States of America. 102 (39): 13795–13800. PMID 16169902.
- Morris GF, Mathews MB (September 1990). "Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1". The Journal of Biological Chemistry. 265 (27): 16116–16125. PMID 1975809.
- Pan ZQ, Chen M, Hurwitz J (January 1993). "The subunits of activator 1 (replication factor C) carry out multiple functions essential for proliferating-cell nuclear antigen-dependent DNA synthesis". Proceedings of the National Academy of Sciences of the United States of America. 90 (1): 6–10. PMID 8093561.
- Prelich G, Kostura M, Marshak DR, Mathews MB, Stillman B (1987). "The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro". Nature. 326 (6112): 471–475. S2CID 4336365.
- Prosperi E (1998). "Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control". Progress in Cell Cycle Research. Vol. 3. pp. 193–210. PMID 9552415.
- Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, et al. (November 1994). "Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen". Science (Submitted manuscript). 266 (5189): 1376–1380. PMID 7973727.
- Szepesi A, Gelfand EW, Lucas JJ (November 1994). "Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes". Blood. 84 (10): 3413–3421. PMID 7949095.
- Travali S, Ku DH, Rizzo MG, Ottavio L, Baserga R, Calabretta B (May 1989). "Structure of the human gene for the proliferating cell nuclear antigen". The Journal of Biological Chemistry. 264 (13): 7466–7472. PMID 2565339.
- Warbrick E, Lane DP, Glover DM, Cox LS (March 1995). "A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen". Current Biology. 5 (3): 275–282. S2CID 1559243.
- Webb G, Parsons P, Chenevix-Trench G (November 1990). "Localization of the gene for human proliferating nuclear antigen/cyclin by in situ hybridization". Human Genetics. 86 (1): 84–86. S2CID 27107553.
External links
- PCNA at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- ANA: Cell cycle related (Mitotic): PCNA type 1 and type 2 Antibody Patterns—Antibody Patterns.com
- Overview of all the structural information available in the PDB for UniProt: P12004 (Proliferating cell nuclear antigen) at the PDBe-KB.